Last Posted: Nov 08, 2018
- Familial Hypercholesterolemia: Clinician and Patient Insights
American College of Cardiology, October 2018 - Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease.
Benito-Vicente Asier et al. International journal of molecular sciences 2018 Nov 19(11) - The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results.
Kullo Iftikhar J et al. Mayo Clinic proceedings 2018 Nov 93(11) 1600-1610 - A Global Call to Action on Familial Hypercholesterolemia
S Seim, The FH Foundation, October 321, 2018 - Healthcare Utilization and Patients' Perspectives After Receiving a Positive Genetic Test for Familial Hypercholesterolemia.
Jones Laney K et al. Circulation. Genomic and precision medicine 2018 Aug 11(8) e002146 - Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia.
Izar Maria Cristina de Oliveira et al. Arquivos brasileiros de cardiologia 2018 Oct 111(4) 585-586 - Management of High and Very High-Risk Subjects with Familial Hypercholesterolemia: Results from an Observational Study in Bulgaria.
Petrov Ivo S et al. Folia medica 2018 Sep 60(3) 389-396 - Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention.
Tscharre Maximilian et al. Journal of clinical lipidology 2018 Sep - Clinical Utility of Genetic Testing in the Diagnosis of Familial Hypercholesterolemia
The FH Foundation webinar, October 25, 2018 - [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
Ferrières J et al. Annales de cardiologie et d'angeiologie 2018 Feb 67(1) 1-8
.png)
No hay comentarios:
Publicar un comentario